SCHEMBL9764158

SCHEMBL9764158

[CH2]C[C@@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL94889 1.00
SCHEMBL25338321 1.00
SCHEMBL28694887 0.85
SCHEMBL2914655 0.83
SCHEMBL580283 0.79
Glycerin SCHEMBL3725402 0.75 LMNA (0.82)
Glycerin SCHEMBL9130517 0.75 LMNA (0.82)
Glycerin SCHEMBL2335853 0.75 LMNA (0.82)
Glycerin SCHEMBL21988052 0.75 LMNA (0.82)
Glycerin SCHEMBL2305273 0.75 LMNA (0.82)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104302634-B Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 诺华股份有限公司 2017-02-08 CN disclosed
US-5036071-A Herper virus MEDIVIR AB (SE) 1991-07-30 US disclosed
EP-0186640-B1 DERIVATIVES OF PURINE, PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL PREPARATION Medivir Aktiebolag (SE) 1990-02-07 EP disclosed
EP-0186640-A1 Derivatives of purine, process for their preparation and a pharmaceutical preparation Medivir Aktiebolag (SE) 1986-07-02 EP disclosed